Development and preliminary evaluation of EMPOWER for surrogate decision-makers of critically ill patients

Abstract

Preliminary data suggest that EMPOWER is feasible, acceptable, and associated with notable improvements in psychological symptoms among surrogates. Future research should examine EMPOWER with a larger sample in a randomized controlled trial.